Teva Pharmaceuticals Inc drugs
17 results
Alvaiz (eltrombopag)
(Eltrombopag)Teva Pharmaceuticals Inc
Usage: ALVAIZ (eltrombopag) is indicated for treating thrombocytopenia in patients with chronic immune thrombocytopenia, chronic hepatitis C, and severe aplastic anemia who have not responded adequately to prior therapies. It is not recommended for myelodysplastic syndromes or when used with certain antiviral agents without interferon.
Alyq (tadalafil)
(Tadalafil)Teva Pharmaceuticals Inc
Usage: ALYQ® (tadalafil tablets) is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability in patients, particularly those with NYHA Functional Class II-III symptoms, including idiopathic, heritable PAH, and PAH tied to connective tissue diseases.
Bicalutamide (bicalutamide)
(bicalutamide)Teva Pharmaceuticals Inc
Usage: Bicalutamide Tablets, USP 50 mg are indicated for combination therapy with an LHRH analog for treating Stage D2 metastatic carcinoma of the prostate. The 150 mg dose is not approved for solo or other treatments.
Deferasirox (deferasirox)
(Deferasirox)Teva Pharmaceuticals Inc
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients 10 and older, with specific liver iron and serum ferritin levels.
Dipentum (olsalazine sodium)
(olsalazine sodium)Teva Pharmaceuticals Inc
Usage: DIPENTUM is indicated for the maintenance of remission in adult patients with ulcerative colitis who are intolerant to sulfasalazine.
Dymista (azelastine hydrochloride and fluticasone propionate)
(Azelastine Hydrochloride and Fluticasone Propionate)Teva Pharmaceuticals Inc
Usage: DYMISTA is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children aged 6 years and older.
Fingolimod (fingolimod)
(Fingolimod)Teva Pharmaceuticals Inc
Usage: Fingolimod capsules are indicated for treating relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients aged 10 years and older.
Fludarabine phosphate (fludarabine phosphate)
(Fludarabine Phosphate)Teva Pharmaceuticals Inc
Lapatinib (lapatinib)
(Lapatinib)Teva Pharmaceuticals Inc
Usage: Lapatinib tablets are indicated for use in combination with capecitabine for advanced/metastatic HER2-positive breast cancer post-prior treatment, and with letrozole for hormone receptor-positive metastatic breast cancer in postmenopausal women. Use is limited to patients with disease progression on trastuzumab prior to lapatinib treatment.
Lenalidomide (lenalidomide)
(Lenalidomide)Teva Pharmaceuticals Inc
Usage: Lenalidomide is indicated for adult patients with multiple myeloma in combination with dexamethasone, transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes with a deletion 5q abnormality, and relapsed or progressed mantle cell lymphoma after two prior therapies. Not recommended for CLL.